The Role of Diet Therapy in Reducing the Cardiovascular Disease Risk in a Patient with a Long-Standing and Recurring History of Obesity

Main Article Content

Rangelova L
Nikolova M

Abstract

Insulin resistance, often referred to as impaired insulin sensitivity. This clinical case focusses on a woman with insulin resistance and a long-standing and recurring history of obesity to demonstrate how diet therapy can be applied in addition to standard medication therapy.

Article Details

L, R., & M, N. (2024). The Role of Diet Therapy in Reducing the Cardiovascular Disease Risk in a Patient with a Long-Standing and Recurring History of Obesity. Journal of Community Medicine and Health Solutions, 5(2), 069–071. https://doi.org/10.29328/journal.jcmhs.1001050
Case Reports

Copyright (c) 2024 Rangelova L, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Freeman AM, Acevedo LA, Pennings N. Insulin resistance. [Updated 2023 Aug 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507839/

Thomas DD, Corkey BE, Istfan NW, Apovian CM. Hyperinsulinemia: an early indicator of metabolic dysfunction. J Endocr Soc. 2019;3(9):1727-1747. Available from: https://doi.org/10.1210/js.2019-00065

Pennings N, Jaber J, Ahiawodzi P. Ten-year weight gain is associated with elevated fasting insulin levels and precedes glucose elevation. Diabetes Metab Res Rev. 2018;34(4). Available from: https://doi.org/10.1002/dmrr.2986

Ogawa W, Araki E, Ishigaki Y, Hirota Y, Maegawa H, Yamauchi T, et al. New classification and diagnostic criteria for insulin resistance syndrome. Endocr J. 2022;69(2):107-113. Available from: https://doi.org/10.1507/endocrj.ej21-0725

Gerich JE. Is insulin resistance the principal cause of type 2 diabetes? Diabetes Obes Metab. 1999;1(5):257-263. Available from: https://doi.org/10.1046/j.1463-1326.1999.00027.x

Engin A. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017;960:1-17. Available from: https://doi.org/10.1007/978-3-319-48382-5_1

Tanase DM, Gosav EM, Costea CF, Ciocoiu M, Lacatusu CM, Maranduca MA, et al. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res. 2020;2020:3920196. Available from: https://doi.org/10.1155/2020/3920196

Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2. Available from: https://doi.org/10.1055/s-2001-18576

Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981-1030. Available from: https://doi.org/10.1210/er.2011-1034

Yaribeygi H, Atkin SL, Simental-Mendía LE, Sahebkar A. Molecular mechanisms by which aerobic exercise induces insulin sensitivity. J Cell Physiol. 2019;234(8):12385-12392. Available from: https://doi.org/10.1002/jcp.28066

Hwalla N, Jaafar Z. Dietary management of obesity: a review of the evidence. Diagnostics. 2021;11(1):24. Available from: https://doi.org/10.3390/diagnostics11010024

Liu D, Huang Y, Huang C, Yang S, Wei X, Zhang P, et al. A study on metabolic outcomes. N Engl J Med. 2022;386:1495-1504. Available from: https://doi.org/10.1056/NEJMoa2114833